Science platform ResearchGate launches COVID-19 community
BERLIN ResearchGate, a social network site for analysts and researchers, has created a new community to help in collaboration involving COVID-19 authorities on study into winning over the flu-like disease because of the story coronavirus.
The site https://www.researchgate.net/community/COVID-19/discussions, developed in week and released late the other day, boosts the visibility of articles, pre-prints together with research suggestions, as well as offering an experienced finder https://www.researchgate.net/COVID-19?utm_source=logged_out_community&utm_medium=RG#contact-form to help construct international or maybe interdisciplinary venture teams.
“We have 11, 000 COVID-19 researchers on ResearchGate – there are huge potential network effects between these scientists, ” said Ijad Madisch, founder and even CEO with the Berlin-based international that has come to be known as ‘Facebook for scientists’.
ResearchGate, and that is backed and others by Microsoft founder Bill Gates plus investment lender Goldman Sachs, has stirred up the staid world of methodical publishing by looking into making it quicker to share researching that have not yet also been subjected to fellow review.
The COVID-19 research community characteristics contributions, fixed by the latest, most read or most recommended, as well as a interactive issue and reply panel to debate popular topics. Content moderation follows soon, added in Madisch.